Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Gross Profit (2016 - 2025)

Historic Gross Profit for Fortress Biotech (FBIO) over the last 11 years, with Q3 2025 value amounting to $11.9 million.

  • Fortress Biotech's Gross Profit rose 1691.28% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.1 million, marking a year-over-year decrease of 434.48%. This contributed to the annual value of $36.8 million for FY2024, which is 4028.56% down from last year.
  • Latest data reveals that Fortress Biotech reported Gross Profit of $11.9 million as of Q3 2025, which was up 1691.28% from $11.5 million recorded in Q2 2025.
  • Fortress Biotech's Gross Profit's 5-year high stood at $28.3 million during Q3 2023, with a 5-year trough of $6.0 million in Q1 2023.
  • Over the past 5 years, Fortress Biotech's median Gross Profit value was $9.9 million (recorded in 2021), while the average stood at $11.1 million.
  • As far as peak fluctuations go, Fortress Biotech's Gross Profit soared by 20431.93% in 2023, and later tumbled by 6413.52% in 2024.
  • Fortress Biotech's Gross Profit (Quarter) stood at $8.8 million in 2021, then dropped by 0.74% to $8.7 million in 2022, then soared by 103.75% to $17.7 million in 2023, then tumbled by 41.01% to $10.4 million in 2024, then rose by 13.75% to $11.9 million in 2025.
  • Its Gross Profit stands at $11.9 million for Q3 2025, versus $11.5 million for Q2 2025 and $8.3 million for Q1 2025.